AstraZeneca to Buy U.S. Vaccine Maker
Wall Street Journal
AstraZeneca said it would buy U.S.-based Icosavax for up to $1.1 billion in a deal that expands its vaccines and immune therapies late-stage pipeline.
https://www.wsj.com/articles/astrazeneca-to-buy-icosavax-for-up-to-1-1-bln-e9f463d2